Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Revenue (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Revenue of $673.06 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), compared with $7.89 million a year earlier.

Analysis

Nurix Therapeutics (NRIX) Revenue (2019 - 2026) Analysis & Trends

On a TTM basis, Nurix Therapeutics' Revenue came in at $701.94 million as of Aug 31, 2026, up 738.8% year-over-year; for FY2025 (ended Nov 30, 2025), it was $83.98 million, up 54.0% from FY2024.

  • Annual Revenue has a five-year compound annual growth rate of 36.3% (FY2020 to FY2025).
  • Across earlier fiscal years, Revenue came in at $54.55 million in FY2024 (-29.1%), $76.99 million in FY2023 (+99.3%), $38.63 million in FY2022 (+29.8%) and $29.75 million in FY2021 (+66.9%).
  • The fiscal Q3 2026 figure is the highest quarterly Revenue in data going back to fiscal Q3 2019.
  • On a year-over-year basis, Revenue rose in three of the last seven quarters, with growth averaging 11.8%.
  • Peak year-over-year performance for Revenue in the last five years was growth of 264.3% in fiscal Q2 2025, against a decline of 79.5% in fiscal Q2 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $9.04 million (Q2 2026), $6.25 million (Q1 2026) and $13.58 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 673.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 673.06 Mn
May 31, 2026 9.04 Mn
Feb 28, 2026 6.25 Mn
Nov 30, 2025 13.58 Mn
Aug 31, 2025 7.89 Mn
May 31, 2025 44.06 Mn
Feb 28, 2025 18.45 Mn
Nov 30, 2024 13.28 Mn
Aug 31, 2024 12.59 Mn
May 31, 2024 12.09 Mn
Feb 29, 2024 16.59 Mn
Nov 30, 2023 15.16 Mn
Aug 31, 2023 18.47 Mn
May 31, 2023 30.68 Mn
Feb 28, 2023 12.69 Mn
Nov 30, 2022 6.78 Mn
Aug 31, 2022 10.79 Mn
May 31, 2022 11.43 Mn
Feb 28, 2022 9.62 Mn
Nov 30, 2021 7.40 Mn
API Access

Nurix Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEY